Gondola Medical Technologies

What Gondola Medical Technologies does

Gondola Medical Technologies SA is a Swiss medical device company headquartered at Biopôle in Epalinges, founded in 2011 by Francesco Cecchini (CEO) and Stefano Tassin (CTO and inventor of the AMPS system). The company develops and commercializes Gondola AMPS (Automated Mechanical Peripheral Stimulation), a CE 0476-certified, internationally patented, non-invasive medical device that applies controlled mechanical pressure to specific points on the soles of both feet in a 2-minute treatment administered every 2 days. The therapy targets motor symptoms of Parkinson's disease — including gait disorders, reduced stride length, freezing of gait, postural instability, and fall risk — by stimulating brain regions involved in movement and balance control. Clinical efficacy has been validated across more than 10 years of research and peer-reviewed studies (Pagnussat et al., Quattrocchi et al., Kleiner et al.) covering over 300 Parkinson's patients, with measurable effects on gait velocity, stride length, Timed Up-and-Go performance, gait symmetry, and dynamic balance observable immediately after treatment.

The underlying technology is purely mechanical and deterministic: no AI, software personalization, or adaptive algorithms are part of the product. The device is regulated under the EU Medical Device Regulation and supervised by Kiwa Cermet Italia Spa. Gondola monetizes through two complementary channels: (1) treatment services delivered at a network of 8 specialized partner centers across Switzerland (Lausanne/Biopôle), Italy (Milan, Varese/Ferno, Ferrara/Copparo, Padua, Brescia), and France (Paris/Villebon-sur-Yvette), and (2) the Gondola Home device sold or rented to patients for self-administered morning therapy. Go-to-market is driven by healthcare provider referrals (neurologists, physiotherapists), direct patient inquiries via phone, WhatsApp, and website forms, and content marketing across a multilingual (IT/FR/DE/EN) website, Facebook, and newsletters. Pricing is not publicly disclosed; patients contact centers directly to book and inquire.

The company is privately held, founder-led, and has been funded primarily through non-dilutive institutional sources rather than commercial venture capital — specifically the EU Horizon 2020 research and innovation programme (grant agreements No. 836225 and No. 946638) and a 2020 grant of approximately $564,462 from the Foundation for Innovation and Technology (FIT). The team comprises fewer than 50 people across leadership, operations, customer service, and clinical delivery. No revenue, ARR, or commercial scale-up funding is disclosed, and the company's commercial footprint remains small relative to its 13-year operating history.

Name

Gondola Medical Technologies

Legal name

Gondola Medical Technologies SA

Website

https://gondola-medical.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Gondola Medical Technologies SA is a Swiss medical device company that commercializes Automated Mechanical Peripheral Stimulation (AMPS), a non-invasive 2-minute foot-stimulation therapy for Parkinson's disease patients, delivered via 8 specialized treatment centers across Switzerland, Italy, and France and a home-use device.

Ownership category

akta.pro rank

Product category

Neurological Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

akta.pro secondary industry

Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC)

Keywords

• Neurological medical devices
• Parkinson's disease therapy
• Non-invasive stimulation
• Gait rehabilitation devices
• Mechanical peripheral stimulation

Headquarters

HQ city

Epalinges

HQ country

Switzerland

HQ region

Europe

Offices8 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. AMPS Therapy Treatment Services: Revenue generated through treatment sessions administered at Gondola's network of specialized centers in Switzerland, Italy, and France. Patients book appointments for the 2-minute AMPS therapy treatment every 2 days. Treatment is compatible with ongoing Parkinson's medications and other therapies.
2. Gondola Home Device Sales: Sale or rental of the Gondola Home device for patients to use AMPS therapy at home. Mentioned in articles about patients using 'Gondola Home device' for morning therapy routines.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Gondola Medical Technologies designs and commercializes the Gondola AMPS (Automated Mechanical Peripheral Stimulation) medical device, which delivers a 2-minute non-invasive therapy that applies precise mechanical pressure to specific points on the soles of both feet to reactivate brain areas controlling gait and balance. The CE 0476 certified device is used to treat motor symptoms of Parkinson's disease and is administered through a network of specialized partner centers in Switzerland, Italy, and France, or via a home-use device.

Product overview

Gondola Medical Technologies offers a single unified product called Gondola AMPS (Automated Mechanical Peripheral Stimulation), a CE-marked medical device that provides non-invasive mechanical stimulation therapy for treating gait and balance disorders in Parkinson's disease patients. The therapy consists of a 2-minute treatment every 2 days that applies precise pressure to specific points on both feet. Treatment is administered through a network of Gondola Specialized Centers in Switzerland, Italy, and France, with the device also available for home use (Gondola Home).

Differentiator

Problem solved

Functional benefit

Products and services

• Gondola AMPS Medical Device CE 0476 certified medical device that delivers Automated Mechanical Peripheral Stimulation (AMPS) — a 2-minute non-invasive treatment applying precise pressure to specific points on both feet to reactivate brain regions controlling gait and balance in Parkinson's disease patients.
• Gondola Specialized Treatment Centers Network of 8 partner treatment centers across Switzerland (Lausanne-Biopôle), Italy (Milan, Varese, Ferrara, Padua, Brescia), and France (Paris) where Parkinson's patients receive Gondola AMPS therapy sessions on a 2-minute-per-treatment, every-2-days cadence.
• Gondola Home Device Home-use version of the Gondola AMPS medical device sold or rented to Parkinson's patients so they can self-administer the 2-minute foot stimulation therapy at home, typically as part of their morning routine.

Quantifiable outcome

• Increased gait velocity and walking speed
• +5 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Helius Medical Technologies: Developer of the Portable Neuromodulation Stimulator (PoNS) device, a non-invasive neurostimulation therapy cleared for neurological rehabilitation including gait and balance deficits — directly comparable to Gondola AMPS in mechanism (mechanical/neuro stimulation) and Parkinson/neurological rehabilitation indication.
• Saebo: Specializes in upper and lower extremity rehabilitation devices for stroke and neurological patients, including functional electrical stimulation (FES) products. Directly comparable as a neurorehabilitation device company serving the same patient population with non-invasive therapy modalities.
• Bionik Laboratories: Develops robotic rehabilitation technologies for patients with neurological mobility impairments (stroke, Parkinson's). Comparable as a neuro-rehab device company with similar clinical goals (restoring gait/motor function) and patient population.

Emerging players

• Cionic: Maker of the Neural Sleeve, a wearable electrical stimulation garment designed to improve gait and mobility for people with neurological conditions including Parkinson's and multiple sclerosis. Comparable as a non-invasive neurostimulation device targeting gait impairments in neurological patients.
• MedRhythms: Neurologic music therapy digital therapeutics platform targeting gait and motor recovery in Parkinson's and stroke patients. Comparable in targeting gait deficits in neurological conditions via a non-pharmacological therapy approach, though delivery is digital rather than mechanical stimulation.
• MicroTransponder: Developer of vagus nerve stimulation (VNS) therapy paired with rehabilitation for stroke and potentially Parkinson's. Comparable as an emerging neurostimulation company targeting gait/motor recovery through pairing device-based neuromodulation with rehabilitation.
• ONWARD Medical: Developer of neuromodulation therapies (including non-invasive transcutaneous systems) to restore movement and function in patients with spinal cord injury and other neurological conditions. Comparable as an emerging neurostimulation company building a non-invasive device therapy for movement disorders.

Broad incumbents

• MindMaze: Digital neurotherapeutics platform with products spanning assessment, therapy, and rehabilitation across multiple neurological conditions including stroke, Parkinson's, and TBI. Comparable as a broader incumbent in neurorehabilitation, though its approach is digital rather than mechanical stimulation.
• Medtronic: Manufactures the Activa deep brain stimulation (DBS) system, a market-leading device therapy for Parkinson's disease motor symptoms. Comparable as a broad incumbent Parkinson therapy provider, though DBS is invasive surgical therapy vs. Gondola's non-invasive mechanical stimulation.
• Abbott: Markets the Infinity DBS system for Parkinson's disease, alongside a broad neurology portfolio. Comparable as a broad incumbent with an established Parkinson's therapy offering, providing context on the competitive landscape for Parkinson's motor symptom treatments.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/gondola-medical-technologies
• Xx.com/gondolamed

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gondola Medical Technologies